Identifying sarcopenia

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 5, 2012, Pages 436-441

  Abellan Van Kan, Gabor ^a,b   Houles, Mathieu ^a   Vellas, Bruno ^a,b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b Faculté de Médecine Centre Hospitalo universitaire   (France)

Author keywords

definitions; diagnosis; older adults; sarcopenia

Indexed keywords

ALGORITHM; DISABILITY; DISEASE SEVERITY; HUMAN; LEAN BODY WEIGHT; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL MOBILITY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SKELETAL MUSCLE;

GAIT; HUMANS; LOCOMOTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; ORGAN SIZE; SARCOPENIA;

EID: 84865525814     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328356bbf4     Document Type: Review

References (23)

1. Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med 1995; 123:727-728.
2. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147:755-763. (Pubitemid 28183275)
3. Newman AB, Kupelian V, Visser M, et al., Health ABC Study Investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51:1602-1609. (Pubitemid 37409595)
4. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13:708-712.
5. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults: current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011; 12:249-256.
6. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39:412-423.
7. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by Special Interest Groups (SIG) 'Cachexia-anorexia in chronic wasting disease' and 'nutrition in geriatrics'. Clin Nutr 2010; 29:154-159.
8. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60:324-333. (Pubitemid 40628797)
9. Clark BC, Manini TM. Sarcopenia 61/4 dynapenia. J Gerontol A Biol Sci Med Sci 2008; 63:829-834.
10. Ferrucci L, Guralnik JM, Studenski S, et al. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004; 52:625-634. (Pubitemid 38480644)
11. Abellan van Kan G, Cederbaum JM, Cesari M, et al. Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research). J Nutr Health Aging 2011; 15:834-846.
12. Abellan van Kan G, Cameron Chumlea W, Gillette-Guyonet S, et al. Clinical trials on sarcopenia: methodological issues regarding phase 3 trials. Clin Geriatr Med 2011; 27:471-482.
13. Bijlsma AY, Meskers CG, Ling CH, et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 2012 [Epub ahead of print].
14. Delmonico MJ, Harris TB, Lee JS, et al., Health ABC Study Investigators. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007; 55:769-774. (Pubitemid 46668965)
15. Morley JE, Abbatecola AM, Argiles JM, et al., Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011; 12:403-409.
16. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009; 13:724-728.
17. Cesari M, Leeuwenburgh C, Lauretani F, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr 2006; 83:1142-1148. (Pubitemid 44713116)
18. Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009; 13:881-889.
19. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011; 305:50-58.
20. Rolland YM, Cesari M, Miller ME, et al. Reliability of the 400-m usual-pace walk test as an assessment of mobility limitation in older adults. J Am Geriatr Soc 2004; 52:972-976. (Pubitemid 38789070)
21. Working Group on Functional Outcome Measures for Clinical Trials. Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 2008; 63:160-164.
22. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003; 95:1851-1860. (Pubitemid 37310367)
23. Sirola J, Kröger H. Similarities in acquired factors related to postmenopausal osteoporosis and sarcopenia. J Osteoporos 2011 [Epub ahead of print].